Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Anesthetic Induction in Laparoscopic Cholecystectomy
NCT07717684Phase 4Recruiting
- Sponsor
- Universidade Federal de Sergipe
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in cholelithiasis (2 arms), sponsored by Universidade Federal de Sergipe. Primary endpoint: Time to Loss of Consciousness up to 5 minutes. Started Aug 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT07717684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717684.